Ligase-mediated programmable genomic integration (L-PGI)
- Angela X Nan 1, Michael Chickering 2, Christopher L Bartolome 1, Neeta Shadija 1, Dan Li 1, Brett J G Estes 1, Jessica Von Stetina 1, Wei Li 1, Jason Andresen 1, Kaivalya Molugu 1, Ravindra Amunugama 1, Minggang Fang 1, Chen Bai 1, Jie Wang 1, Davood Norouzi 1, Jesse C Cochrane 1, Jason T Gatlin 1, Maike Thamsen Dunyak 1, Sandeep Kumar 1, Leonard Chavez 2, Anmol Seth 2, Shakked Halperin 3, Jonathan D Finn 4, Jenny Xie 5
- 1Tome Biosciences Inc, Watertown, MA, USA.
- 2Replace Therapeutics, LLC, a direct and wholly owned subsidiary of Tome Biosciences Inc, Berkeley, CA, USA.
- 3Replace Therapeutics, LLC, a direct and wholly owned subsidiary of Tome Biosciences Inc, Berkeley, CA, USA. shakkedhalperin@gmail.com.
- 4Tome Biosciences Inc, Watertown, MA, USA. jdfinn@outlook.com.
- 5Tome Biosciences Inc, Watertown, MA, USA. jx46@netzero.com.
- 0Tome Biosciences Inc, Watertown, MA, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new ligase-based CRISPR gene editing method enables precise DNA modifications without double-stranded breaks, showing promise in various cell types and in vivo for genomic medicine applications.
Area Of Science
- Molecular Biology
- Genetics
- Biotechnology
Background
- CRISPR systems are versatile tools for programmable genomic editing.
- Current methods like Cas9 nickase with reverse transcriptase have limitations, especially in post-mitotic cells.
- These limitations hinder in vivo applications and translatability.
Purpose Of The Study
- To develop a novel ligase-based gene editing method.
- To overcome the limitations of existing CRISPR-based editing techniques, particularly in challenging cell types.
- To demonstrate the efficacy and applicability of this new method in various biological systems.
Main Methods
- Utilizing Cas9 nickase to create targeted genomic nicks.
- Employing a ligase-based approach for the delivery and integration of synthetic DNA donors.
- Testing the method in cell lines, primary cell cultures, and adult mice using nonviral delivery.
Main Results
- Demonstrated editing activity in diverse cell types, including primary cells and in vivo models.
- Achieved favorable on-target editing outcomes compared to transcription-based methods.
- Showcased good tolerability and efficient nonviral deliverability of the editing components.
Conclusions
- The novel ligase-mediated gene editing method offers a promising alternative for precise genomic modifications.
- This approach addresses limitations of previous technologies, enhancing applicability in post-mitotic cells and in vivo.
- Ligation-mediated gene editing holds significant potential for advancing genomic medicine and therapeutic applications.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:53
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
02:57
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...

